QingSong Health (HKG:2661) launched its initial public offering in Hong Kong on Monday, looking to raise up to HK$601.9 million.
The telehealth company is offering as many as 26.5 million H shares at an indicative price of HK$22.68 apiece, according to a filing Monday.
The issuer expects to disclose allocations on Dec. 22 and begin trading on the Hong Kong bourse on Dec. 23.
The company secured Aoqin Heming as a cornerstone investor, which committed to subscribing to a total of 100 million yuan worth of IPO shares.
QingSong Health will use the IPO proceeds to increase its brand visibility and market position, as well as to enhance user engagement and deepen cooperation with business partners.
China International Capital Corporation, China Merchants Securities (HK), Futu Securities International (Hong Kong), and SPDB International Capital are the joint bookrunners of the IPO.
Comments